A study to look at the effectiveness and safety of of Alogliptin Plus Metformin, Alogliptin Alone, or Metformin Alone in Subjects with Diabetes
- Registry ID
- EUCTR2009-012652-24
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Takeda Global Research and Development Centre (Europe) Ltd.
- Start date
- 2010-03-23
- Completion date
- 2011-06-30
- Last update
- 2026-08-16
Conditions
- Type II diabetes mellitus (T2DM)
Summary
To evaluate the efficacy of combination of alogliptin BID plus metformin BID as compared with alogliptin BID alone or metformin BID alone on HbA1c change from Baseline at Week 26 (or at time of discontinuation of double-blind study medication or hyperglycemic rescue).
Locations
- , , Czechia
- , , Lithuania
- , , Hungary
- , , Slovakia
View on source registry